Back to search

Article

Global Genomic Surveillance Reveals Pre-EUA Fixation of Pemivibart (VYD2311) Escape Constellations in SARS-CoV-2

2025-12-23

Abstract excerpt

Pemivibart (VYD222) and its successor, VYD2311, target a shared, evolutionarily vulnerable epitope in the SARS-CoV-2 spike receptor-binding domain (RBD). Although VYD2311 an IND features an Fc-mediated half-life extension and demonstrates a reported 17-fold increase in in vitro neutralization potency over pemivibart (marketed as Pemgarda™, VYD222), both antibodies engage identical contact residues - R346, K444, F4...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d992b7f9-69e3-5c1b-8915-1b9b9f74c9bd
DOI
10.20944/preprints202512.2013.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Global Genomic Surveillance Reveals Pre-EUA Fixation of Pemivibart (VYD2311) Escape Constellations in SARS-CoV-2DOI 10.20944/preprints202512.2013.v1
Select a neighboring publication to make it the new centre.